The Limited Times

Now you can see non-English news...

Covid: Aifa alert for antiviral instead of vaccine

2021-09-10T15:28:42.911Z


It is called Parvulan and is a drug indicated for the treatment of Herpes Zoster, illegal in Italy, but is used as a replacement for the Anticovid vaccine. Aifa reports this in an opinion of the Technical Scientific Commission, published on its website. (HANDLE)


In the period 27 December 2020 - 26 August 2021

, 91,360 reports of suspected adverse reactions were received out of a total of 76,509,846 doses of anti-Covid vaccine administered (reporting rate of 119 per 100,000 doses), of which 86.1% reported to non-serious events, such as pain at the injection site, fever, asthenia / fatigue, muscle aches. This was reported by the Italian Medicines Agency in the eighth Pharmacovigilance Report on Covid Vaccines. The data collected and analyzed concern the reports of suspected adverse reactions registered in the National Pharmacovigilance Network for the 4 vaccines in use in the vaccination campaign. 

Serious reports, says AIFA, correspond to 13.8% of the total, with a rate of 13 serious events per 100,000 doses administered. As reported in previous Reports, regardless of the vaccine, dose and type of event, the reaction occurred in most cases (about 80%) on the same day of vaccination or the next day and only more rarely beyond 48 hours. following. Comirnaty is currently the most used vaccine in the Italian vaccination campaign (71%), followed by Vaxzevria (16%), Spikevax (11%) and COVID-19 Vaccino Janssen (2%). In line with previous Reports, the distribution of reports by type of vaccine is similar to that of administrations (Comirnaty 67%, Vaxzevria 24%, Spikevax 8%, COVID-19 vaccine Janssen 1%). For all vaccines,the most reported adverse events are fever, fatigue, headache, muscle / joint pain, local reaction or pain at the injection site, chills and nausea. In relation to the so-called heterologous vaccinations to people under 60 who had received Vaxzevria as the first dose, 248 reports were received, out of a total of 604,865 administrations (the second dose concerned Comirnaty in 76% of cases and Spikevax in 24%) , with a reporting rate of 41 for every 100,000 doses administered.865 administrations (the second dose concerned Comirnaty in 76% of cases and Spikevax in 24%), with a reporting rate of 41 per 100,000 doses administered.865 administrations (the second dose concerned Comirnaty in 76% of cases and Spikevax in 24%), with a reporting rate of 41 per 100,000 doses administered.

Meanwhile, there is the alarm from AIFA for the use of an antiviral instead of the vaccine

.

It is called Parvulan and is a drug indicated for the treatment of Herpes Zoster, illegal in Italy, but is used as a replacement for the Anticovid vaccine.

Aifa reports this in an opinion of the Technical Scientific Commission, published on its website.

The drug, used for the so-called shingles, is not authorized.

The alert was triggered following the increase in suspicious import requests.

"The use of the drug in the prophylaxis of Sars-CoV-2, is explained in the opinion" is not supported by the slightest evidence of efficacy and safety "and is" a potential danger to people's health ".


Source: ansa

All life articles on 2021-09-10

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.